ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

MEIP MEI Pharma Inc

3.06
0.00 (0.00%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
MEI Pharma Inc MEIP 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 3.06 09:00:00
개장가 저가 고가 종가 전일 종가
3.13 3.06 3.21 3.06 3.06
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
11/04/202421:02BWMEI Pharma Board of Directors Aligns on Strategy to Advance..
11/04/202421:00BWMEI Pharma Reports Initial Data from Clinical Study..
10/04/202421:00BWMEI Pharma to Present at the Stifel 2024 Virtual Targeted..
26/03/202421:00BWMEI Pharma Reports Update from Clinical Study Evaluating..
29/02/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
22/02/202406:00EDGAR2Form 8-K - Current report
21/02/202407:33EDGAR2Form S-3 - Registration statement under Securities Act of..
14/02/202407:05EDGAR2Form 8-K - Current report
14/02/202407:05BWMEI Pharma Reports Second Quarter Fiscal Year 2024 Results..
18/01/202406:00EDGAR2Form 8-K - Current report
17/01/202407:00BWMEI Pharma to Present Design of Ongoing Clinical Study..
27/12/202307:00EDGAR2Form 8-K - Current report
23/12/202306:00EDGAR2Form 8-K - Current report
21/12/202311:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202311:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202306:00EDGAR2Form 8-K - Current report
12/12/202306:00EDGAR2Form 8-K - Current report
12/12/202302:00BWMEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor..
15/11/202310:59EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/11/202306:06EDGAR2Form 8-K - Current report
10/11/202306:05BWMEI Pharma Reports First Quarter Fiscal Year 2024 Results..
10/11/202306:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202307:03EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
09/11/202307:02EDGAR2Form DEF 14A - Other definitive proxy statements
08/11/202322:00BWMEI Pharma to Present at the Stifel 2023 Healthcare..
07/11/202306:57BWMEI Pharma Declares Special Cash Dividend of $1.75 Per Share..
04/11/202307:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/11/202322:00BWMEI Pharma Announces Acceptance of Abstract for Presentation..
02/11/202306:20EDGAR2Form SC 13D/A - General statement of acquisition of..
02/11/202306:15EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
02/11/202305:54EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
02/11/202305:01EDGAR2Form 8-K - Current report
01/11/202322:00BWMEI Pharma Enters into Agreement with Anson Funds and Cable..
28/10/202305:05EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
25/10/202308:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/10/202308:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/10/202306:00EDGAR2Form SC 13D/A - General statement of acquisition of..
18/10/202306:33BWMEI Pharma Recommends Stockholders Not to Consent
18/10/202306:28EDGAR2Form DEFC14A - Definitive proxy statement, contested..
14/10/202306:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/10/202306:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/10/202306:00EDGAR2Form SC 13D/A - General statement of acquisition of..
13/10/202308:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202308:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202308:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202308:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202308:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202306:25EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
11/10/202304:00EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
10/10/202323:33EDGAR2Form DEFC14A - Definitive proxy statement, contested..

최근 히스토리

Delayed Upgrade Clock